23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
434.41%
Revenue growth exceeding 1.5x Insurance - Life median of 16.54%. Joel Greenblatt would verify if operating margins keep pace with this top-line surge.
434.41%
Gross profit growth exceeding 1.5x Insurance - Life median of 16.54%. Joel Greenblatt would check if cost advantages or brand equity drive this surge.
4723.81%
EBIT growth exceeding 1.5x Insurance - Life median of 35.29%. Joel Greenblatt would examine whether a unique competitive edge supports this outperformance.
4723.81%
Operating income growth exceeding 1.5x Insurance - Life median of 35.29%. Joel Greenblatt would see if unique processes drive exceptional profitability.
841.55%
Net income growth exceeding 1.5x Insurance - Life median of 80.23%. Joel Greenblatt would check if brand strength or cost advantages fuel this outperformance.
842.24%
EPS growth exceeding 1.5x Insurance - Life median of 80.26%. Joel Greenblatt would confirm if consistent earnings expansion underpins these gains.
841.54%
Diluted EPS growth exceeding 1.5x Insurance - Life median of 80.25%. Joel Greenblatt would confirm if strong net income growth or buybacks drive outperformance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-34.02%
Negative OCF growth while Insurance - Life median is -14.12%. Seth Klarman would ask if accounting or macro issues hamper the firm specifically.
-34.02%
Negative FCF growth while Insurance - Life median is -15.88%. Seth Klarman would see if others in the industry are still generating positive expansions in free cash.
52.59%
10Y revenue/share CAGR exceeding 1.5x Insurance - Life median of 19.39%. Joel Greenblatt would verify if a unique moat or brand fosters outperformance over a decade.
244.75%
5Y revenue/share growth exceeding 1.5x Insurance - Life median of 24.56%. Joel Greenblatt would see if the company’s moat drives rapid mid-term expansion.
-5.37%
Negative 3Y CAGR while Insurance - Life median is 6.71%. Seth Klarman would examine if the sector is otherwise stable, indicating a company-specific issue.
429.90%
OCF/share CAGR exceeding 1.5x Insurance - Life median of 37.10% over 10 years. Joel Greenblatt would verify if a unique competitive moat underlies these cash flows.
20.42%
5Y OCF/share growth 1.25-1.5x Insurance - Life median. Mohnish Pabrai would see if consistent operational improvements enable better cash yields.
93.73%
3Y OCF/share growth > 1.5x Insurance - Life median of 2.18%. Joel Greenblatt might see a recent competitive advantage translating into cash improvements.
35.39%
Net income/share CAGR exceeding 1.5x Insurance - Life median of 5.93% over a decade. Joel Greenblatt might see a standout compounder of earnings.
10.86%
5Y net income/share CAGR 75-90% of Insurance - Life median. John Neff would encourage better profitability or share buybacks to catch up with peers.
68.81%
3Y net income/share CAGR > 1.5x Insurance - Life median of 5.88%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.
58.58%
Equity/share CAGR exceeding 1.5x Insurance - Life median of 24.78% over 10 years. Joel Greenblatt would see if a high ROE underlies this compounding advantage.
71.66%
5Y equity/share CAGR > 1.5x Insurance - Life median of 36.27%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.
40.39%
3Y equity/share CAGR > 1.5x Insurance - Life median of 21.32%. Joel Greenblatt sees strong short-term returns on equity fueling net worth growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
5.09%
AR growth of 5.09% while Insurance - Life median is zero. Walter Schloss checks if the difference points to new credit strategy or stronger sales push.
No Data
No Data available this quarter, please select a different quarter.
1.06%
Asset growth 50-75% of Insurance - Life median. Guy Spier sees potential underinvestment or overcaution vs. peers.
2.59%
1.25-1.5x Insurance - Life median. Mohnish Pabrai sees disciplined reinvestment or strong earnings retention behind outperformance.
7.49%
Debt growth of 7.49% while Insurance - Life median is zero. Walter Schloss might see a modest difference that matters if interest coverage is tight.
No Data
No Data available this quarter, please select a different quarter.
-6.92%
SG&A decline while Insurance - Life grows. Seth Klarman sees potential cost advantage or a risk if it hurts future growth.